Picture of Bluejay Diagnostics logo

BJDX — Bluejay Diagnostics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Bluejay Diagnostics Reports Q1 Results

May 10 (Reuters) - Bluejay Diagnostics Inc  BJDX.O :
    * BLUEJAY DIAGNOSTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
    * BLUEJAY DIAGNOSTICS INC - CASH AND CASH EQUIVALENTS ON
MARCH 31,
2023 WERE $6.8 MILLION, AS COMPARED TO $10.1 MILLION ON DECEMBER
31, 2022
    * BLUEJAY DIAGNOSTICS INC - WILL LIMIT ITS CASH BURN DURING
FDA
SUBMISSION PROCESS AND CONTINUE TO CLOSELY MONITOR MANAGEMENT OF
ITS LIQUIDITY
    * BLUEJAY DIAGNOSTICS INC - QTRLY LOSS PER SHARE $0.12
    * BLUEJAY DIAGNOSTICS INC - LOOK FORWARD TO PROVIDING AN
UPDATE ON
OUR SYMPHONY IL-6 CLINICAL PROGRAM DURING THIS QUARTER

Source text for Eikon:  ID:nGNX4HxqyG 
Further company coverage:  BJDX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Bluejay Diagnostics

See all news